Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-2-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-4707
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
251-7
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:3795919-Aerobiosis,
pubmed-meshheading:3795919-Doping in Sports,
pubmed-meshheading:3795919-Energy Metabolism,
pubmed-meshheading:3795919-Humans,
pubmed-meshheading:3795919-Oxygen Consumption,
pubmed-meshheading:3795919-Physical Exertion,
pubmed-meshheading:3795919-Sports Medicine,
pubmed-meshheading:3795919-Sympathomimetics
|
pubmed:year |
1986
|
pubmed:articleTitle |
The effects of a sympathomimetic drug on maximal aerobic capacity.
|
pubmed:publicationType |
Journal Article
|